MOIE to investigate Gemcitabine patent infringement.
Published: 2005-11-21 06:58:00
Updated: 2005-11-21 06:58:00
The Trade Commission of the Ministry of Industry and Energy took the 225th meeting on Nov. 12 and decided to investigate an unfair trade act by infringing the patent rights of gemcitabine, an anti-cancer drug owned by E. Lilly.
E. Lilly claimed that local "K" and "S" drug company imported a bu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
